ResMed Pre-Tax Profit Margin 2010-2023 | RMD
Current and historical pre-tax profit margin for ResMed (RMD) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. ResMed pre-tax profit margin for the three months ending December 31, 2023 was .
| ResMed Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $4.50B | $1.10B | 24.36% |
| 2023-09-30 | $4.38B | $1.11B | 25.42% |
| 2023-06-30 | $4.22B | $1.10B | 26.10% |
| 2023-03-31 | $4.02B | $1.06B | 26.47% |
| 2022-12-31 | $3.76B | $1.00B | 26.57% |
| 2022-09-30 | $3.63B | $0.96B | 26.57% |
| 2022-06-30 | $3.58B | $0.96B | 26.82% |
| 2022-03-31 | $3.54B | $0.96B | 27.15% |
| 2021-12-31 | $3.44B | $0.95B | 27.67% |
| 2021-09-30 | $3.35B | $0.93B | 27.68% |
| 2021-06-30 | $3.20B | $0.88B | 27.65% |
| 2021-03-31 | $3.09B | $0.86B | 27.73% |
| 2020-12-31 | $3.09B | $0.83B | 26.88% |
| 2020-09-30 | $3.03B | $0.80B | 26.40% |
| 2020-06-30 | $2.96B | $0.73B | 24.83% |
| 2020-03-31 | $2.89B | $0.62B | 21.38% |
| 2019-12-31 | $2.78B | $0.56B | 20.26% |
| 2019-09-30 | $2.70B | $0.53B | 19.67% |
| 2019-06-30 | $2.61B | $0.52B | 19.92% |
| 2019-03-31 | $2.53B | $0.56B | 22.34% |
| 2018-12-31 | $2.46B | $0.56B | 22.65% |
| 2018-09-30 | $2.41B | $0.55B | 22.95% |
| 2018-06-30 | $2.34B | $0.52B | 22.26% |
| 2018-03-31 | $2.27B | $0.50B | 22.08% |
| 2017-12-31 | $2.20B | $0.48B | 21.86% |
| 2017-09-30 | $2.13B | $0.43B | 20.42% |
| 2017-06-30 | $2.07B | $0.42B | 20.28% |
| 2017-03-31 | $2.03B | $0.41B | 20.41% |
| 2016-12-31 | $1.97B | $0.42B | 21.09% |
| 2016-09-30 | $1.89B | $0.43B | 22.87% |
| 2016-06-30 | $1.84B | $0.44B | 23.86% |
| 2016-03-31 | $1.77B | $0.43B | 24.01% |
| 2015-12-31 | $1.74B | $0.43B | 24.74% |
| 2015-09-30 | $1.71B | $0.43B | 25.32% |
| 2015-06-30 | $1.68B | $0.44B | 25.98% |
| 2015-03-31 | $1.64B | $0.44B | 26.77% |
| 2014-12-31 | $1.62B | $0.44B | 27.10% |
| 2014-09-30 | $1.58B | $0.43B | 27.33% |
| 2014-06-30 | $1.56B | $0.43B | 27.72% |
| 2014-03-31 | $1.56B | $0.41B | 26.50% |
| 2013-12-31 | $1.54B | $0.41B | 26.41% |
| 2013-09-30 | $1.53B | $0.40B | 25.81% |
| 2013-06-30 | $1.52B | $0.39B | 25.40% |
| 2013-03-31 | $1.47B | $0.40B | 26.88% |
| 2012-12-31 | $1.44B | $0.37B | 25.87% |
| 2012-09-30 | $1.39B | $0.36B | 25.61% |
| 2012-06-30 | $1.37B | $0.33B | 24.25% |
| 2012-03-31 | $1.34B | $0.31B | 23.15% |
| 2011-12-31 | $1.30B | $0.30B | 22.79% |
| 2011-09-30 | $1.28B | $0.29B | 22.96% |
| 2011-06-30 | $1.24B | $0.30B | 24.46% |
| 2011-03-31 | $1.19B | $0.30B | 25.06% |
| 2010-12-31 | $1.16B | $0.30B | 25.54% |
| 2010-09-30 | $1.13B | $0.28B | 24.82% |
| 2010-06-30 | $1.09B | $0.26B | 23.88% |
| 2010-03-31 | $1.05B | $0.25B | 23.84% |
| 2009-12-31 | $1.00B | $0.24B | 23.65% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $25.568B | $4.223B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Stryker (SYK) | United States | $127.849B | 31.70 |
| Medtronic (MDT) | Ireland | $105.004B | 14.86 |
| Boston Scientific (BSX) | United States | $99.704B | 33.15 |
| EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
| Terumo (TRUMY) | Japan | $24.880B | 35.14 |
| Baxter (BAX) | United States | $20.069B | 14.64 |
| Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
| Insulet (PODD) | United States | $11.642B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
| Demant (WILYY) | Denmark | $10.001B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
| BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
| Perrigo (PRGO) | Ireland | $4.071B | 11.64 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.378B | 15.97 |
| Envista Holdings (NVST) | United States | $3.367B | 12.80 |
| Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
| ICU Medical (ICUI) | United States | $2.336B | 17.43 |
| TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| Owens & Minor (OMI) | United States | $1.836B | 17.62 |
| Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
| InMode (INMD) | Israel | $1.465B | 7.59 |
| LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
| AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
| Warby Parker (WRBY) | United States | $1.189B | 0.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| MacroGenics (MGNX) | United States | $1.007B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
| BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
| Evolus (EOLS) | United States | $0.674B | 0.00 |
| Jin Medical (ZJYL) | China | $0.631B | 0.00 |
| Quanterix (QTRX) | United States | $0.602B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.538B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
| PetIQ (PETQ) | United States | $0.469B | 17.50 |
| ZimVie (ZIMV) | United States | $0.417B | 25.55 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.388B | 44.70 |
| Surmodics (SRDX) | United States | $0.378B | 40.80 |
| Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
| Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
| Veru (VERU) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Fonar (FONR) | United States | $0.105B | 8.98 |
| Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Safety Shot (SHOT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
| ProSomnus (OSA) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |